FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016036506> ?p ?o ?g. }

• W2016036506 endingPage "2641" @default.
• W2016036506 startingPage "2632" @default.
• W2016036506 abstract "The tumor suppressor Tip60 regulates gene transcription, DNA damage response, apoptosis, and cancer development, but its role in melanoma is unknown. In this study, we investigated the expression pattern of Tip60 in melanoma and assessed its prognostic value. Using tissue microarrays consisting of 448 cases of melanomas (201 for the training set and 247 for the validation set) and 105 cases of nevi, we found that Tip60 expression was significantly reduced in metastatic melanoma compared to common nevi (P=0.045), dysplastic nevi (P=0.047), and primary melanoma (P=0.001). Kaplan–Meier survival curve and univariate Cox regression analyses showed that reduced Tip60 expression was associated with a poorer 5-year disease-specific survival in primary melanoma (P=0.016) and metastatic melanoma patients (P=0.027). Multivariate Cox regression analyses indicated that Tip60 expression was an independent prognostic marker for primary (P=0.024) and metastatic melanomas (P=0.035). In vitro wound healing assay showed that enforced Tip60 expression inhibited but Tip60 knockdown enhanced melanoma cell migration, suggesting that Tip60 might regulate melanoma metastasis. Finally, we showed that overexpression of Tip60 in melanoma cells resulted in significantly increased chemosensitivity. Our data indicate that Tip60 may serve as a potential biomarker for melanoma patient outcome as well as a potential therapeutic target. The tumor suppressor Tip60 regulates gene transcription, DNA damage response, apoptosis, and cancer development, but its role in melanoma is unknown. In this study, we investigated the expression pattern of Tip60 in melanoma and assessed its prognostic value. Using tissue microarrays consisting of 448 cases of melanomas (201 for the training set and 247 for the validation set) and 105 cases of nevi, we found that Tip60 expression was significantly reduced in metastatic melanoma compared to common nevi (P=0.045), dysplastic nevi (P=0.047), and primary melanoma (P=0.001). Kaplan–Meier survival curve and univariate Cox regression analyses showed that reduced Tip60 expression was associated with a poorer 5-year disease-specific survival in primary melanoma (P=0.016) and metastatic melanoma patients (P=0.027). Multivariate Cox regression analyses indicated that Tip60 expression was an independent prognostic marker for primary (P=0.024) and metastatic melanomas (P=0.035). In vitro wound healing assay showed that enforced Tip60 expression inhibited but Tip60 knockdown enhanced melanoma cell migration, suggesting that Tip60 might regulate melanoma metastasis. Finally, we showed that overexpression of Tip60 in melanoma cells resulted in significantly increased chemosensitivity. Our data indicate that Tip60 may serve as a potential biomarker for melanoma patient outcome as well as a potential therapeutic target. confidential interval hazard ratio sulforhodamine B" @default.
• W2016036506 created "2016-06-24" @default.
• W2016036506 creator A5011834043 @default.
• W2016036506 creator A5046228592 @default.
• W2016036506 creator A5051489318 @default.
• W2016036506 creator A5074942308 @default.
• W2016036506 creator A5080952282 @default.
• W2016036506 date "2012-11-01" @default.
• W2016036506 modified "2023-09-25" @default.
• W2016036506 title "Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival" @default.
• W2016036506 cites W1505083232 @default.
• W2016036506 cites W1565276921 @default.
• W2016036506 cites W174577041 @default.
• W2016036506 cites W1894150445 @default.
• W2016036506 cites W1969396454 @default.
• W2016036506 cites W1975660840 @default.
• W2016036506 cites W1977979223 @default.
• W2016036506 cites W1982545065 @default.
• W2016036506 cites W1984246427 @default.
• W2016036506 cites W1985110168 @default.
• W2016036506 cites W1994577866 @default.
• W2016036506 cites W2006257070 @default.
• W2016036506 cites W2013429896 @default.
• W2016036506 cites W2014039677 @default.
• W2016036506 cites W2017622305 @default.
• W2016036506 cites W2022094921 @default.
• W2016036506 cites W2023597079 @default.
• W2016036506 cites W2025838418 @default.
• W2016036506 cites W2034269086 @default.
• W2016036506 cites W2034331383 @default.
• W2016036506 cites W2038324148 @default.
• W2016036506 cites W2040735698 @default.
• W2016036506 cites W2040898244 @default.
• W2016036506 cites W2041882103 @default.
• W2016036506 cites W2055276204 @default.
• W2016036506 cites W2065027509 @default.
• W2016036506 cites W2070403360 @default.
• W2016036506 cites W2081099987 @default.
• W2016036506 cites W2086635837 @default.
• W2016036506 cites W2093775600 @default.
• W2016036506 cites W2102584939 @default.
• W2016036506 cites W2106543129 @default.
• W2016036506 cites W2111578933 @default.
• W2016036506 cites W2114886355 @default.
• W2016036506 cites W2115667633 @default.
• W2016036506 cites W2120707752 @default.
• W2016036506 cites W2122706742 @default.
• W2016036506 cites W2131819768 @default.
• W2016036506 cites W2132678065 @default.
• W2016036506 cites W2135493854 @default.
• W2016036506 cites W2136381907 @default.
• W2016036506 cites W2144654038 @default.
• W2016036506 cites W2171045529 @default.
• W2016036506 cites W4240458912 @default.
• W2016036506 cites W4244068819 @default.
• W2016036506 cites W4386007350 @default.
• W2016036506 doi "https://doi.org/10.1038/jid.2012.193" @default.
• W2016036506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22673729" @default.
• W2016036506 hasPublicationYear "2012" @default.
• W2016036506 type Work @default.
• W2016036506 sameAs 2016036506 @default.
• W2016036506 citedByCount "53" @default.
• W2016036506 countsByYear W20160365062013 @default.
• W2016036506 countsByYear W20160365062014 @default.
• W2016036506 countsByYear W20160365062015 @default.
• W2016036506 countsByYear W20160365062016 @default.
• W2016036506 countsByYear W20160365062017 @default.
• W2016036506 countsByYear W20160365062018 @default.
• W2016036506 countsByYear W20160365062019 @default.
• W2016036506 countsByYear W20160365062020 @default.
• W2016036506 countsByYear W20160365062021 @default.
• W2016036506 countsByYear W20160365062022 @default.
• W2016036506 countsByYear W20160365062023 @default.
• W2016036506 crossrefType "journal-article" @default.
• W2016036506 hasAuthorship W2016036506A5011834043 @default.
• W2016036506 hasAuthorship W2016036506A5046228592 @default.
• W2016036506 hasAuthorship W2016036506A5051489318 @default.
• W2016036506 hasAuthorship W2016036506A5074942308 @default.
• W2016036506 hasAuthorship W2016036506A5080952282 @default.
• W2016036506 hasBestOaLocation W20160365061 @default.
• W2016036506 hasConcept C121608353 @default.
• W2016036506 hasConcept C126322002 @default.
• W2016036506 hasConcept C143998085 @default.
• W2016036506 hasConcept C173396325 @default.
• W2016036506 hasConcept C190283241 @default.
• W2016036506 hasConcept C193270364 @default.
• W2016036506 hasConcept C2777658100 @default.
• W2016036506 hasConcept C2779013556 @default.
• W2016036506 hasConcept C502942594 @default.
• W2016036506 hasConcept C55493867 @default.
• W2016036506 hasConcept C71924100 @default.
• W2016036506 hasConcept C86803240 @default.
• W2016036506 hasConceptScore W2016036506C121608353 @default.
• W2016036506 hasConceptScore W2016036506C126322002 @default.
• W2016036506 hasConceptScore W2016036506C143998085 @default.
• W2016036506 hasConceptScore W2016036506C173396325 @default.
• W2016036506 hasConceptScore W2016036506C190283241 @default.
• W2016036506 hasConceptScore W2016036506C193270364 @default.

• next